Ticker history: PTHL became ITOC (iTonic Holdings Ltd) on . Earlier news and filings retain their original names and dates. View PTHL history.
What Changed
Price Move History
- Daily moves over 5%
- 82 252 sessions, November 13, 2025 to November 13, 2026
- Largest daily move
- +105% close of January 15, 2026
- 1-year change
- -79.8% closing prices, November 13, 2025 to November 13, 2026
- 1-month change
- -49.7% closing prices, October 13, 2026 to November 13, 2026
Company Description
iTonic Holdings Ltd (ITOC) provides healthcare solutions for brachytherapy, a targeted form of radiation therapy used in cancer treatment. The company operates through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., and focuses on treatment planning systems and related products and services used in brachytherapy procedures.
The company's lead product is Beijing Feitian's Treatment Planning System. The system supports planning for brachytherapy, in which radioactive sources are placed inside the patient to kill cancer cells and shrink tumors. iTonic's reported product portfolio also includes medical auxiliary supplies associated with brachytherapy procedures, such as seed implant needles, computer workstations and patient positioning devices.
iTonic Holdings was founded in 1998 and is based in Beijing, China. Its Class A ordinary shares are associated with Nasdaq listing requirements, including the minimum bid price rule disclosed in the company's public communications. The company's public-company profile is therefore defined by both its China-based healthcare-technology operating subsidiary and its status as a listed issuer reporting corporate, governance and capital-structure matters.
Stock Performance
iTonic Holdings (ITOC) closed at $1.98 on November 13, 2026. Over the past 12 months, the price has lost 79.8%.
ITOC Metrics & Rankings
Price returns through November 13, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
iTonic Holdings has 4 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 2 with negative movement. Key topics include AI. View all ITOC news →
SEC Filings
iTonic Holdings has filed 10 recent SEC filings, including 8 Form 6-K, 1 Form 3, 1 Form 20-F/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ITOC SEC filings →
Financial Highlights
iTonic Holdings generated $523K in revenue in FY2025, retaining a 62.6% gross margin, operating income reached -$5.2M, and net income was -$5.1M. Diluted earnings per share stood at -$0.32. The company generated -$3.2M in operating cash flow. The current ratio was 8.83, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in iTonic Holdings (ITOC) currently stands at 4.0 thousand shares, down 59.9% from the previous reporting period, representing 0.1% of the float.
Days to Cover History
Days to cover for iTonic Holdings (ITOC) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 4.1 days.
ITOC Company Profile & Sector Positioning
iTonic Holdings (ITOC) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing ITOC often look at related companies in the same sector, including SANUWAVE Health, Inc. (SNWV), PAVmed Inc. (PAVM), CVRx, Inc. (CVRX), Cytosorbents Corp. (CTSO), and Iridex Corp (IRIX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ITOC's relative position within its industry.